Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-CD27, 1F5 Vector   (CAT#: GTVCR-WQ66MR)

This product GTVCR-WQ66MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting CD27. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001242.5
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 939
UniProt ID P26842
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-CD27, 1F5 Vector (GTVCR-WQ66MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1074MR IVTScrip™ pT7-VEE-mRNA-Anti-Factor IX substitute, CSL654 Vector Vector CSL654
GTVCR-WQ266MR IVTScrip™ pSP6-VEE-mRNA-Anti-MSTN, ACE-031 Vector Vector ACE-031
GTVCR-WQ1276MR IVTScrip™ pT7-VEE-mRNA-Anti-CSF3R, G-CSF-Fc-PEG Vector Vector G-CSF-Fc-PEG
GTVCR-WQ2462MR IVTScrip™ pSP6-VEE-mRNA-Anti-SELP, SEG101 Vector Vector SEG101
GTVCR-WQ141MR IVTScrip™ pSP6-VEE-mRNA-Anti-AXL, Ab-2 Vector Vector Ab-2
GTVCR-WQ1448MR IVTScrip™ pT7-VEE-mRNA-Anti-AXL, HuMax-AXL-ADC Vector Vector HuMax-AXL-ADC
GTVCR-WQ2650MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD3E&SSTR2, XmAb-18087 Vector Vector XmAb-18087
GTVCR-WQ776MR IVTScrip™ pT7-VEE-mRNA-Anti-KIR2DL1&KIR2DL2&KIR2DL3&KIR2DS1&KIR2DS2, BMS-986015 Vector Vector BMS-986015
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.